Immunolocalization of AQP5 in resting and stimulated normal labial glands and in Sjögren's syndrome

V. Gresz, A. Horvath, I. Gera, S. Nielsen, T. Zelles

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

Objective: In our current work, in vivo examination of AQP5 distribution in labial salivary glands following stimulation of secretion has been carried out in normal individuals and in patients with Sjögren's syndrome. Subjects and Methods: For this study, we selected five patients with primary Sjögren's syndrome (mean age 62.4 ± 10.6 s.d. years) diagnosed in accordance with the European Cooperative Community classification criteria. There were five patients (mean age 27 ± 2.5 s.d. years) in the control group. The subcellular distribution of AQP5 in human labial gland biopsies was determined with light and immunoelectron microscopy before and 30 min after administration of oral pilocarpine. Results: In unstimulated control and Sjögren's labial glands, AQP5 is about 90% localized in the apical plasma membrane, with only rarely associated gold particles with intracellular membrane structures. We have found no evidence of pilocarpine-induced changes in localization of AQP5 in either healthy individuals or patients with Sjögren's syndrome. Conclusions: Our studies indicate that neither Sjögren's syndrome itself, nor muscarinic cholinergic stimulation in vivo caused any significant changes in the distribution of AQP5 in the labial salivary gland cells.

Original languageEnglish
Pages (from-to)e114-e120
JournalOral Diseases
Volume21
Issue number1
DOIs
Publication statusPublished - Jan 1 2015

Fingerprint

Lip
Pilocarpine
Salivary Glands
Cholinergic Agents
Intracellular Membranes
Immunoelectron Microscopy
European Union
Gold
Oral Administration
Cell Membrane
Biopsy
Light
Control Groups

Keywords

  • Aquaporin-5
  • Oral pilocarpine
  • Salivary secretion
  • Sjögren's syndrome

ASJC Scopus subject areas

  • Dentistry(all)
  • Otorhinolaryngology

Cite this

Immunolocalization of AQP5 in resting and stimulated normal labial glands and in Sjögren's syndrome. / Gresz, V.; Horvath, A.; Gera, I.; Nielsen, S.; Zelles, T.

In: Oral Diseases, Vol. 21, No. 1, 01.01.2015, p. e114-e120.

Research output: Contribution to journalArticle

@article{02f18fa96b7b4d36917d6eff847cc612,
title = "Immunolocalization of AQP5 in resting and stimulated normal labial glands and in Sj{\"o}gren's syndrome",
abstract = "Objective: In our current work, in vivo examination of AQP5 distribution in labial salivary glands following stimulation of secretion has been carried out in normal individuals and in patients with Sj{\"o}gren's syndrome. Subjects and Methods: For this study, we selected five patients with primary Sj{\"o}gren's syndrome (mean age 62.4 ± 10.6 s.d. years) diagnosed in accordance with the European Cooperative Community classification criteria. There were five patients (mean age 27 ± 2.5 s.d. years) in the control group. The subcellular distribution of AQP5 in human labial gland biopsies was determined with light and immunoelectron microscopy before and 30 min after administration of oral pilocarpine. Results: In unstimulated control and Sj{\"o}gren's labial glands, AQP5 is about 90{\%} localized in the apical plasma membrane, with only rarely associated gold particles with intracellular membrane structures. We have found no evidence of pilocarpine-induced changes in localization of AQP5 in either healthy individuals or patients with Sj{\"o}gren's syndrome. Conclusions: Our studies indicate that neither Sj{\"o}gren's syndrome itself, nor muscarinic cholinergic stimulation in vivo caused any significant changes in the distribution of AQP5 in the labial salivary gland cells.",
keywords = "Aquaporin-5, Oral pilocarpine, Salivary secretion, Sj{\"o}gren's syndrome",
author = "V. Gresz and A. Horvath and I. Gera and S. Nielsen and T. Zelles",
year = "2015",
month = "1",
day = "1",
doi = "10.1111/odi.12239",
language = "English",
volume = "21",
pages = "e114--e120",
journal = "Oral Diseases",
issn = "1354-523X",
publisher = "Wiley-Blackwell",
number = "1",

}

TY - JOUR

T1 - Immunolocalization of AQP5 in resting and stimulated normal labial glands and in Sjögren's syndrome

AU - Gresz, V.

AU - Horvath, A.

AU - Gera, I.

AU - Nielsen, S.

AU - Zelles, T.

PY - 2015/1/1

Y1 - 2015/1/1

N2 - Objective: In our current work, in vivo examination of AQP5 distribution in labial salivary glands following stimulation of secretion has been carried out in normal individuals and in patients with Sjögren's syndrome. Subjects and Methods: For this study, we selected five patients with primary Sjögren's syndrome (mean age 62.4 ± 10.6 s.d. years) diagnosed in accordance with the European Cooperative Community classification criteria. There were five patients (mean age 27 ± 2.5 s.d. years) in the control group. The subcellular distribution of AQP5 in human labial gland biopsies was determined with light and immunoelectron microscopy before and 30 min after administration of oral pilocarpine. Results: In unstimulated control and Sjögren's labial glands, AQP5 is about 90% localized in the apical plasma membrane, with only rarely associated gold particles with intracellular membrane structures. We have found no evidence of pilocarpine-induced changes in localization of AQP5 in either healthy individuals or patients with Sjögren's syndrome. Conclusions: Our studies indicate that neither Sjögren's syndrome itself, nor muscarinic cholinergic stimulation in vivo caused any significant changes in the distribution of AQP5 in the labial salivary gland cells.

AB - Objective: In our current work, in vivo examination of AQP5 distribution in labial salivary glands following stimulation of secretion has been carried out in normal individuals and in patients with Sjögren's syndrome. Subjects and Methods: For this study, we selected five patients with primary Sjögren's syndrome (mean age 62.4 ± 10.6 s.d. years) diagnosed in accordance with the European Cooperative Community classification criteria. There were five patients (mean age 27 ± 2.5 s.d. years) in the control group. The subcellular distribution of AQP5 in human labial gland biopsies was determined with light and immunoelectron microscopy before and 30 min after administration of oral pilocarpine. Results: In unstimulated control and Sjögren's labial glands, AQP5 is about 90% localized in the apical plasma membrane, with only rarely associated gold particles with intracellular membrane structures. We have found no evidence of pilocarpine-induced changes in localization of AQP5 in either healthy individuals or patients with Sjögren's syndrome. Conclusions: Our studies indicate that neither Sjögren's syndrome itself, nor muscarinic cholinergic stimulation in vivo caused any significant changes in the distribution of AQP5 in the labial salivary gland cells.

KW - Aquaporin-5

KW - Oral pilocarpine

KW - Salivary secretion

KW - Sjögren's syndrome

UR - http://www.scopus.com/inward/record.url?scp=84919455986&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84919455986&partnerID=8YFLogxK

U2 - 10.1111/odi.12239

DO - 10.1111/odi.12239

M3 - Article

C2 - 24661359

AN - SCOPUS:84919455986

VL - 21

SP - e114-e120

JO - Oral Diseases

JF - Oral Diseases

SN - 1354-523X

IS - 1

ER -